» Articles » PMID: 35265424

Autoimmune Pancreatitis Masquerading As Pancreatic Cancer: A Case Report and Literature Review

Overview
Journal Cureus
Date 2022 Mar 10
PMID 35265424
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune pancreatitis (AIP) is a chronic fibro-inflammatory disease of the pancreas that belongs to the spectrum of immunoglobulin G-subclass 4-related diseases (IgG4-RD). It is sometimes associated with a visible pancreatic mass mimicking pancreatic cancer on imaging. The most common presentations include abdominal pain and obstructive jaundice in elderly men. Similar to other IgG4-RD, it can cause cholangiopathy, nephritis, orbital pseudotumor, and extensive lymphadenopathy. Here, we present the case of a 53-year-old female with abdominal pain and obstructive jaundice, which was diagnosed as AIP in association with significantly elevated tumor marker carbohydrate antigen 19-9 (CA 19-9). She responded to biliary decompression and steroid treatment, potentially avoiding extensive surgical intervention. On follow-up, her CA 19-9 and IgG4 levels were normalized. AIP should be high on the differential diagnosis during the evaluation of a pancreatic mass.

Citing Articles

Diagnostic Differentiation between Pancreatitis and Pancreatic Cancer: A Scoping Review.

Madela F, Ferndale L, Aldous C Diagnostics (Basel). 2024; 14(3).

PMID: 38337806 PMC: 10855106. DOI: 10.3390/diagnostics14030290.


Type 1 Autoimmune Pancreatitis Masquerading as Pancreatic Head Carcinoma.

Agboola A, Mohamed K, Syed M, Shiwlani S, Butt R, Reza R Cureus. 2023; 15(10):e47471.

PMID: 38022068 PMC: 10662655. DOI: 10.7759/cureus.47471.

References
1.
Ghazale A, Chari S, Smyrk T, Levy M, Topazian M, Takahashi N . Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007; 102(8):1646-53. DOI: 10.1111/j.1572-0241.2007.01264.x. View

2.
Shimosegawa T, Chari S, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M . International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011; 40(3):352-8. DOI: 10.1097/MPA.0b013e3182142fd2. View

3.
Farrell J, Garber J, Sahani D, Brugge W . EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc. 2004; 60(6):927-36. DOI: 10.1016/s0016-5107(04)02230-8. View

4.
Raina A, Yadav D, Krasinskas A, McGrath K, Khalid A, Sanders M . Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009; 104(9):2295-306. PMC: 6583795. DOI: 10.1038/ajg.2009.325. View

5.
Buijs J, van Heerde M, Rauws E, Maillette de Buy Wenniger L, Hansen B, Biermann K . Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis. Pancreas. 2014; 43(2):261-7. DOI: 10.1097/MPA.0000000000000044. View